PTC Therapeutics | PTCT - PE价格收益



金融业
股票价格
USD
资产
USD 3.25B
现金及等价物
USD 1.05B
销售成本
USD 39.61M
流动资产
USD 2.62B
流动负债
USD 771.07M
债务
USD 286.94M
EBIT
USD 45.89M
EBITDA
USD 61.98M
员工
939
EPS每股收益
USD 0.92
股本和储备
USD -165.36M
销售毛利
USD 232.94M
债务利息支出
USD 3.25B
贷款资金
USD 535.52M
市值
USD 5.15B
净收入
USD -2.81M
营业费用
USD 226.67M
营业利润
USD 45.89M
普通股股本
USD 82.88M
PE价格收益
8.76
税前利润
USD -2.46M
销售收入
USD 361M
销售和管理费用
USD 73.89M
股票
USD 91.35M
贸易债权人
USD 40.45M
应收帐款人
USD 219.92M


Pe 更改 日
Acadia Pharmaceuticals 11.33 1.25 2026-06
Alnylam Pharmaceuticals 75.64 4.4 2026-06
Amgen 18.07 1.77 2026-06
BioCryst Pharmaceuticals 6.84 0.78 2026-06
Biogen 23.23 9.53 2026-06
BioMarin Pharmaceutical 21.07 5.79 2026-06
Daiichi Sankyo 20.14 0.6 2026-06
Gilead Sciences 13.51 4.2 2026-06
Incyte 14.45 0.9 2026-06
Ionis Pharmaceuticals 396.15 79.28 2022-09
Ironwood Pharmaceuticals 204.24 88.19 2024-12
Novartis 22.41 2.24 2026-06
Pfizer 11.48 2.16 2026-06
PTC Therapeutics 8.76 1.22 2026-03
Puma Biotechnology 13.93 44.88 2024-06
Roche Holding 16.48 0.39 2026-06
Sarepta Therapeutics 27.27 0 2026-03
TG Therapeutics 19.64 7.65 2026-06
Vertex Pharmaceuticals 28.05 2.22 2026-06
Xencor 29.92 3.22 2022-09